248 related articles for article (PubMed ID: 25756516)
1. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.
Subbannayya Y; Syed N; Barbhuiya MA; Raja R; Marimuthu A; Sahasrabuddhe N; Pinto SM; Manda SS; Renuse S; Manju HC; Zameer MA; Sharma J; Brait M; Srikumar K; Roa JC; Vijaya Kumar M; Kumar KV; Prasad TS; Ramaswamy G; Kumar RV; Pandey A; Gowda H; Chatterjee A
Cancer Biol Ther; 2015; 16(2):336-45. PubMed ID: 25756516
[TBL] [Abstract][Full Text] [Related]
2. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract][Full Text] [Related]
3. Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated Carcinogenesis in Gastric Cancer.
Najar MA; Modi PK; Ramesh P; Sidransky D; Gowda H; Prasad TSK; Chatterjee A
J Proteome Res; 2021 May; 20(5):2687-2703. PubMed ID: 33844560
[TBL] [Abstract][Full Text] [Related]
4. Akt activation by Ca
Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
[TBL] [Abstract][Full Text] [Related]
5. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
6. microRNA-9 attenuates amyloidβ-induced synaptotoxicity by targeting calcium/calmodulin-dependent protein kinase kinase 2.
Chang F; Zhang LH; Xu WP; Jing P; Zhan PY
Mol Med Rep; 2014 May; 9(5):1917-22. PubMed ID: 24603903
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
8. CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.
Penfold L; Woods A; Muckett P; Nikitin AY; Kent TR; Zhang S; Graham R; Pollard A; Carling D
Cancer Res; 2018 Dec; 78(24):6747-6761. PubMed ID: 30242113
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.
Shima T; Mizokami A; Miyagi T; Kawai K; Izumi K; Kumaki M; Ofude M; Zhang J; Keller ET; Namiki M
Prostate; 2012 Dec; 72(16):1789-801. PubMed ID: 22549914
[TBL] [Abstract][Full Text] [Related]
10. CaMKK2 Suppresses Muscle Regeneration through the Inhibition of Myoblast Proliferation and Differentiation.
Ye C; Zhang D; Zhao L; Li Y; Yao X; Wang H; Zhang S; Liu W; Cao H; Yu S; Wang Y; Jiang J; Wang H; Li X; Ying H
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783047
[TBL] [Abstract][Full Text] [Related]
11. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
Popovics P; Frigo DE; Schally AV; Rick FG
Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
[TBL] [Abstract][Full Text] [Related]
12. Identification of Differentiation-Related Proteins in Gastric Adenocarcinoma Tissues by Proteomics.
Zhou X; Yao K; Zhang L; Zhang Y; Han Y; Liu HL; Liu XW; Su G; Yuan WZ; Wei XD; Guan QL; Zhu BD
Technol Cancer Res Treat; 2016 Oct; 15(5):697-706. PubMed ID: 27624754
[TBL] [Abstract][Full Text] [Related]
13. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
[TBL] [Abstract][Full Text] [Related]
14. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
Fu H; He HC; Han ZD; Wan YP; Luo HW; Huang YQ; Cai C; Liang YX; Dai QS; Jiang FN; Zhong WD
Tumour Biol; 2015 Mar; 36(3):1983-91. PubMed ID: 25394900
[TBL] [Abstract][Full Text] [Related]
16. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
[TBL] [Abstract][Full Text] [Related]
17. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
[TBL] [Abstract][Full Text] [Related]
18. Activity-Based Protein Profiling Reveals Potential Dasatinib Targets in Gastric Cancer.
Choi KM; Cho E; Bang G; Lee SJ; Kim B; Kim JH; Park SG; Han EH; Chung YH; Kim JY; Kim E; Kim JY
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291786
[TBL] [Abstract][Full Text] [Related]
19. IGFBP-2 stimulates calcium/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.
Xi G; D'Costa S; Wai C; Xia SK; Cox ZC; Clemmons DR
J Cell Physiol; 2019 Dec; 234(12):23232-23242. PubMed ID: 31155724
[TBL] [Abstract][Full Text] [Related]
20. Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2).
Chen Y; Whitefield B; Nevius E; Hill M; DelRosario J; Sinitsyna N; Shanmugasundaram V; Mukherjee D; Shi L; Mayne CG; Rousseau AM; Bernard SM; Buenviaje J; Khambatta G; El Samin M; Wallace M; Nie Z; Sivakumar P; Hamann LG; McDonnell DP; D'Agostino LA
J Med Chem; 2023 Dec; 66(23):15750-15760. PubMed ID: 38009718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
